Novo Nordisk plans to offer Wegovy in vials as well as its usual format. The report gives no timing or pricing yet.
Recap by typeshit. Full story at Meteo.gr.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Dr. Regina DePietro of MU Health Care says unapproved peptides sold for research lack the safety checks Ozempic went through, and suggests asking a doctor first.
Photos online users uploaded mostly matched what they reported, but over 65% on compounded semaglutide or tirzepatide called it the brand version, Medscape reports.
Loading…